The National Eczema Association (NEA) is opening  its 2020 research grant cycle.

Applications must be received by Monday, Aug. 31, 2020 at 5 p.m. PDT, and recipients will be announced in November.

For the 2020 funding cycle, NEA has grants available in each of the following categories:

  • Engagement Research Grant – up to $5,000
  • Small research grants for emerging investigators intended to explore a new research concept, pilot a new experiment or undertake a novel or secondary data analysis.
  • Catalyst Research Grant – up to $50,000
  • Grants designed to support talented early-career scientists on the path toward becoming the next generation of eczema thought leaders by supporting hypothesis-driven research projects.
  • Eczema Champion Research Grant – up to $100,000
  • Grants to encourage proven researchers to continue research on emerging or ongoing challenges in eczema or bring their expertise to the field of eczema.

Applications for 2020 Research Grants are requested for the following research priorities established by NEA's Scientific & Medical Advisory Council:

  • Cutting Edge Basic & Translational Science
  • Eczema Heterogeneity: Novel Insights
  • Innovations in Clinical Practice & Care
  • Understanding & Alleviating Disease Burden
  • Eczema Prevention

NEA has invested more than $1.4 million to date to support a deeper understanding of eczema, provide insights into new treatment strategies and improve care and prevention. To date, NEA research grants have supported 37 novel research investigations and 31 unique grant awardees, resulting in more than 2,900 citations of NEA-funded research publications. And, most importantly, NEA grants have spurred further investment in eczema research. For every $1 from NEA, grantees have collectively gone on to obtain an additional $11.84 in subsequent National Institutes of Health (NIH) funding to support further research.

"Amid the coronavirus pandemic and with so many shifting allocations of research resources, it is all the more critical that we remain steadfast in our support of innovative eczema research that can advance awareness and treatment of this prevalent skin disease," says Julie Block, president and CEO of NEA, in a news release.